Publications
484 publications
- Date
- Relevance
-
Zostavax for the prevention of Herpes Zoster and Postherpetic Neuralgia
The primary efficacy outcome of the SPS is vaccine efficacy for the burden of illness (BOI), a composite endpoint affected by the ...
-
Trastuzuma (Herceptin) for HER2-positive early breast cancer
Recommendation by the National Health Care Institute [Zorginstituut Nederland] dated 10-09-2013, based on a re-evaluation by the ...
-
COPD Package Scan
In 2007 there were almost 324,000 people with COPD (Chronic Obstructive Pulmonary Disease) in the Netherlands. The quality of ...
-
Nalmefene (Selincro) in cases of alcohol dependence
The WAR has drawn up a pharmacotherapeutic report for the medicine nalmefene (Selincro) in a film-coated tablet with 18.06 mg ...
-
Ingenol mebutate (Picato) for the cutaneous treatment of actinic keratosis
The WAR has drawn up a pharmacotherapeutic report for the medicine ingenol mebutate (Picato). Its therapeutic value was ...
-
Vemurafenib (Zelboraf) for the indication ‘BRAF V600 mutation-positive unresectable or metastatic melanoma’
Vemurafenib has an added therapeutic value in comparison with decarbazine for the treatment of adult patients in a relatively ...
-
Lidocaine-tetracaine plaster (Rapydan) for the indication surface anaesthesia of the skin
For surface anaesthesia of the skin in connection with needle puncture in children from 3 years of age and adults, and in cases ...
-
Donepezil hydrochloride (Aspen) for the indication symptomatic treatment of mild to moderately severe Alzheimer’s dementia
The WAR has drawn up a pharmacotherapeutic report for the medicine donepezil (hydrochloride) Aspen film-coated tablets. Its ...
-
Ruxolitinib (Jakavi) for the indication symptomatic treatment of myelofibrosis
Ruxolitinib has an added value in comparison with placebo or BAT in the treatment of the disease-related splenomegaly or symptoms ...
-
Ulipristal (Esmya) for preoperative treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age
The applicant claims that treatment with ulipristal is a cost-effective intervention for the preoperative treatment of moderate ...